No Data
Why Paymentus Holdings Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket
SciSparc Shares Are Soaring Monday: What's Going On?
SciSparc-Clearmind Collaboration Leads to Publication of Patent Application for Cocaine Addiction Psychedelic Combination Treatment in South Korea
Clearmind Wins South Korea Patent for Psychedelic Therapy Targeting Cocaine Addiction
SciSparc Will Sell 4,961 Shares Of MitoCareX To N2OFF For $700,000 And Exchange Its Remaining Shares For Common Stock In N2OFF; Receives 40% Of N2OFF Stock; Entitled To Up To 25% Additional Based On Milestones; 30% Financing Proceeds Over 5-Years...
SciSparc Signs Definitive Agreement to Sell MitoCareX, Computational Drug Discovery Company Targeting Resistant Cancers
